Laurent Moll Sells 9,219 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 9,219 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $20.85, for a total value of $192,216.15. Following the completion of the sale, the chief operating officer owned 212,478 shares of the company’s stock, valued at $4,430,166.30. This trade represents a 4.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Arteris Trading Down 1.0%

Arteris stock traded down $0.20 during trading on Tuesday, reaching $20.41. 557,821 shares of the company were exchanged, compared to its average volume of 729,086. Arteris, Inc. has a 52-week low of $8.75 and a 52-week high of $50.26. The company has a market capitalization of $1.00 billion, a P/E ratio of -23.46 and a beta of 1.91. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. The stock’s 50 day simple moving average is $27.54 and its two-hundred day simple moving average is $27.81.

Arteris (NASDAQ:AIP) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. On average, equities research analysts expect that Arteris, Inc. will post -0.68 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on AIP shares. Jefferies Financial Group raised shares of Arteris from a “hold” rating to a “buy” rating and upped their price objective for the company from $35.00 to $50.00 in a report on Friday, August 7th. Weiss Ratings raised shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 21st. Roth Capital started coverage on shares of Arteris in a research note on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price target for the company. Oppenheimer assumed coverage on shares of Arteris in a report on Thursday, July 16th. They set an “outperform” rating and a $40.00 price target for the company. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $38.00 price target on shares of Arteris in a research report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Arteris currently has a consensus rating of “Moderate Buy” and an average target price of $41.00.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of AIP. Needham Investment Management LLC raised its holdings in Arteris by 2.6% in the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after buying an additional 86,500 shares during the period. BlackRock Inc. acquired a new stake in shares of Arteris during the second quarter valued at about $160,129,000. Granahan Investment Management LLC increased its position in shares of Arteris by 201.0% during the first quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock valued at $11,723,000 after acquiring an additional 476,181 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock valued at $24,305,000 after acquiring an additional 1,897 shares during the period. Finally, Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter worth approximately $11,602,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property company that provides network-on-chip (NoC) interconnect and system IP for the design of complex systems-on-chip (SoCs). Its technologies help semiconductor and electronics companies connect processor cores, memory, peripherals and other functional blocks within a chip while supporting data movement, system integration and design reuse.

The company’s product portfolio includes FlexNoC interconnect IP, Ncore cache-coherent interconnect IP and CodaCache system IP.